Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 265

1.

Novel column generation-based optimization approach for poly-pathway kinetic model applied to CHO cell culture.

Hagrot E, Oddsdóttir HÆ, Mäkinen M, Forsgren A, Chotteau V.

Metab Eng Commun. 2018 Dec 25;8:e00083. doi: 10.1016/j.mec.2018.e00083. eCollection 2019 Jun.

2.

MAGDALENA: study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero.

Heinonen E, Szymanska-von Schultz B, Kaldo V, Nasiell J, Andersson E, Bergmark M, Blomdahl-Wetterholm M, Forsberg L, Forsell E, Forsgren A, Frööjd S, Goldman A, Nordenadler EM, Sklivanioti M, Blennow M, Wide K, Gustafsson LL.

BMJ Open. 2018 Aug 5;8(8):e023281. doi: 10.1136/bmjopen-2018-023281.

3.

Increased accuracy of planning tools for optimization of dynamic multileaf collimator delivery of radiotherapy through reformulated objective functions.

Engberg L, Eriksson K, Forsgren A.

Phys Med Biol. 2018 Jun 13;63(12):125012. doi: 10.1088/1361-6560/aac70a.

PMID:
29786611
4.

Toward robust adaptive radiation therapy strategies.

Böck M, Eriksson K, Forsgren A, Hårdemark B.

Med Phys. 2017 Jun;44(6):2054-2065. doi: 10.1002/mp.12226. Epub 2017 Jun 1.

PMID:
28317129
5.

Explicit optimization of plan quality measures in intensity-modulated radiation therapy treatment planning.

Engberg L, Forsgren A, Eriksson K, Hårdemark B.

Med Phys. 2017 Jun;44(6):2045-2053. doi: 10.1002/mp.12146. Epub 2017 May 4.

PMID:
28160520
6.

Robustness analysis of elementary flux modes generated by column generation.

Oddsdóttir HÆ, Hagrot E, Chotteau V, Forsgren A.

Math Biosci. 2016 Mar;273:45-56. doi: 10.1016/j.mbs.2015.12.009. Epub 2015 Dec 31.

PMID:
26748294
7.

Maximizing the probability of satisfying the clinical goals in radiation therapy treatment planning under setup uncertainty.

Fredriksson A, Forsgren A, Hårdemark B.

Med Phys. 2015 Jul;42(7):3992-9. doi: 10.1118/1.4921998.

PMID:
26133599
8.

On dynamically generating relevant elementary flux modes in a metabolic network using optimization.

Oddsdóttir HÆ, Hagrot E, Chotteau V, Forsgren A.

J Math Biol. 2015 Oct;71(4):903-20. doi: 10.1007/s00285-014-0844-1. Epub 2014 Oct 17.

PMID:
25323319
9.

High incidence of septic shock caused by Streptococcus pneumoniae serotype 3--a retrospective epidemiological study.

Ahl J, Littorin N, Forsgren A, Odenholt I, Resman F, Riesbeck K.

BMC Infect Dis. 2013 Oct 22;13:492. doi: 10.1186/1471-2334-13-492.

10.

Increase of β-lactam-resistant invasive Haemophilus influenzae in Sweden, 1997 to 2010.

Resman F, Ristovski M, Forsgren A, Kaijser B, Kronvall G, Medstrand P, Melander E, Odenholt I, Riesbeck K.

Antimicrob Agents Chemother. 2012 Aug;56(8):4408-15. doi: 10.1128/AAC.00415-12. Epub 2012 Jun 11.

11.

Comparing health outcomes and costs of general vaccination with pneumococcal conjugate vaccines in Sweden: a Markov model.

By A, Sobocki P, Forsgren A, Silfverdal SA.

Clin Ther. 2012 Jan;34(1):177-89. doi: 10.1016/j.clinthera.2011.12.007.

PMID:
22284997
12.

Minimax optimization for handling range and setup uncertainties in proton therapy.

Fredriksson A, Forsgren A, Hårdemark B.

Med Phys. 2011 Mar;38(3):1672-84.

PMID:
21520880
13.

Use of medical resources and indirect costs of otitis media in Sweden.

Speets AM, Wolleswinkel JH, Forsgren A, Sobocki PA.

Scand J Public Health. 2011 Mar;39(2):137-46. doi: 10.1177/1403494810393553. Epub 2011 Jan 21.

PMID:
21257647
14.

Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains.

Resman F, Ristovski M, Ahl J, Forsgren A, Gilsdorf JR, Jasir A, Kaijser B, Kronvall G, Riesbeck K.

Clin Microbiol Infect. 2011 Nov;17(11):1638-45. doi: 10.1111/j.1469-0691.2010.03417.x. Epub 2011 Feb 14.

15.

Prevention of otitis media: now a reality?

Schuerman L, Borys D, Hoet B, Forsgren A, Prymula R.

Vaccine. 2009 Sep 25;27(42):5748-54. doi: 10.1016/j.vaccine.2009.07.070. Epub 2009 Aug 8. Review.

PMID:
19666154
16.

Nontypeable Haemophilus influenzae adhesin protein E: characterization and biological activity.

Ronander E, Brant M, Eriksson E, Mörgelin M, Hallgren O, Westergren-Thorsson G, Forsgren A, Riesbeck K.

J Infect Dis. 2009 Feb 15;199(4):522-31. doi: 10.1086/596211.

PMID:
19125675
17.

Nontypeable Haemophilus influenzae as a pathogen in children.

Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, Virji M, Pelton SI.

Pediatr Infect Dis J. 2009 Jan;28(1):43-8. doi: 10.1097/INF.0b013e318184dba2. Review.

PMID:
19057458
18.

Haemophilus influenzae interacts with the human complement inhibitor factor H.

Hallström T, Zipfel PF, Blom AM, Lauer N, Forsgren A, Riesbeck K.

J Immunol. 2008 Jul 1;181(1):537-45.

19.

The Moraxella IgD-binding protein MID/Hag is an oligomeric autotransporter.

Hallström T, Müller SA, Mörgelin M, Möllenkvist A, Forsgren A, Riesbeck K.

Microbes Infect. 2008 Apr;10(4):374-81. doi: 10.1016/j.micinf.2007.12.015. Epub 2008 Jan 3.

PMID:
18400547
20.

Moraxella catarrhalis-dependent tonsillar B cell activation does not lead to apoptosis but to vigorous proliferation resulting in nonspecific IgM production.

Jendholm J, Samuelsson M, Cardell LO, Forsgren A, Riesbeck K.

J Leukoc Biol. 2008 Jun;83(6):1370-8. doi: 10.1189/jlb.1107788. Epub 2008 Mar 27.

PMID:
18372337
21.

Purification of alpha1-antichymotrypsin from human plasma with recombinant M. catarrhalis ubiquitous surface protein A1.

Manolov T, Forsgren A, Riesbeck K.

J Immunol Methods. 2008 Apr 20;333(1-2):180-5. doi: 10.1016/j.jim.2007.12.012. Epub 2008 Jan 15.

PMID:
18242635
22.

Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.

Forsgren A, Riesbeck K, Janson H.

Clin Infect Dis. 2008 Mar 1;46(5):726-31. doi: 10.1086/527396. Review.

PMID:
18230042
23.

Moraxella-dependent alpha 1-antichymotrypsin neutralization: a unique virulence mechanism.

Manolov T, Tan TT, Forsgren A, Riesbeck K.

Am J Respir Cell Mol Biol. 2008 May;38(5):609-17. Epub 2007 Dec 20.

PMID:
18096871
24.

Identification of a novel Haemophilus influenzae protein important for adhesion to epithelial cells.

Ronander E, Brant M, Janson H, Sheldon J, Forsgren A, Riesbeck K.

Microbes Infect. 2008 Jan;10(1):87-96. Epub 2007 Oct 22. Erratum in: Microbes Infect. 2015 Jun;17(6):e2.

PMID:
18069033
25.

Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.

Simán JH, Engstrand L, Berglund G, Forsgren A, Florén CH.

Scand J Gastroenterol. 2007 Aug;42(8):933-40.

PMID:
17613922
26.

Characterization of the IgD binding site of encapsulated Haemophilus influenzae serotype b.

Samuelsson M, Hallström T, Forsgren A, Riesbeck K.

J Immunol. 2007 May 15;178(10):6316-9.

27.

Haemophilus influenzae survival during complement-mediated attacks is promoted by Moraxella catarrhalis outer membrane vesicles.

Tan TT, Morgelin M, Forsgren A, Riesbeck K.

J Infect Dis. 2007 Jun 1;195(11):1661-70. Epub 2007 Apr 17.

PMID:
17471436
28.

Purification of IgD from human serum--a novel application of recombinant M. catarrhalis IgD-binding protein (MID).

Samuelsson M, Forsgren A, Riesbeck K.

J Immunol Methods. 2006 Dec 20;317(1-2):31-7. Epub 2006 Oct 4.

PMID:
17056056
29.

Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.

Tan TT, Christensen JJ, Dziegiel MH, Forsgren A, Riesbeck K.

Infect Immun. 2006 Nov;74(11):6377-86. Epub 2006 Sep 11.

30.
31.

The IgD CH1 region contains the binding site for the human respiratory pathogen Moraxella catarrhalis IgD-binding protein MID.

Samuelsson M, Jendholm J, Amisten S, Morrison SL, Forsgren A, Riesbeck K.

Eur J Immunol. 2006 Sep;36(9):2525-34.

32.

The respiratory pathogen moraxella catarrhalis binds to laminin via ubiquitous surface proteins A1 and A2.

Tan TT, Forsgren A, Riesbeck K.

J Infect Dis. 2006 Aug 15;194(4):493-7. Epub 2006 Jul 7.

PMID:
16845633
33.

Haemophilus influenzae surface fibrils contribute to serum resistance by interacting with vitronectin.

Hallström T, Trajkovska E, Forsgren A, Riesbeck K.

J Immunol. 2006 Jul 1;177(1):430-6. Erratum in: J Immunol. 2013 Apr 15;190(8):4431.

34.

Iterative regularization in intensity-modulated radiation therapy optimization.

Carlsson F, Forsgren A.

Med Phys. 2006 Jan;33(1):225-34.

PMID:
16485429
35.

The IgD-binding domain of the Moraxella IgD-binding protein MID (MID962-1200) activates human B cells in the presence of T cell cytokines.

Nordström T, Jendholm J, Samuelsson M, Forsgren A, Riesbeck K.

J Leukoc Biol. 2006 Feb;79(2):319-29. Epub 2005 Nov 21.

PMID:
16301327
36.

Ionic binding of C3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity.

Nordström T, Blom AM, Tan TT, Forsgren A, Riesbeck K.

J Immunol. 2005 Sep 15;175(6):3628-36.

37.

The respiratory pathogen Moraxella catarrhalis adheres to epithelial cells by interacting with fibronectin through ubiquitous surface proteins A1 and A2.

Tan TT, Nordström T, Forsgren A, Riesbeck K.

J Infect Dis. 2005 Sep 15;192(6):1029-38. Epub 2005 Aug 12.

PMID:
16107956
38.

[National contact tracing of tuberculosis should be introduced].

Petrini B, Boman G, Forsgren A.

Lakartidningen. 2005 Mar 21-Apr 3;102(12-13):977. Swedish. No abstract available.

PMID:
15887644
39.

Evaluation of western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects.

Simán JH, Engstrand L, Berglund G, Florén CH, Forsgren A.

Clin Diagn Lab Immunol. 2005 Feb;12(2):304-9.

40.

The CD19 molecule is crucial for MID-dependent activation of tonsillar B cells from children.

Hadzic R, Forsgren A, Cardell LO, Riesbeck K, Wingren AG.

Scand J Immunol. 2005 Feb;61(2):165-72.

41.
44.
45.

Several gene programs are induced in ciprofloxacin-treated human lymphocytes as revealed by microarray analysis.

Eriksson E, Forsgren A, Riesbeck K.

J Leukoc Biol. 2003 Sep;74(3):456-63.

PMID:
12949250
46.

The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin.

Forsgren A, Brant M, Karamehmedovic M, Riesbeck K.

Infect Immun. 2003 Jun;71(6):3302-9.

47.

The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation.

Möllenkvist A, Nordström T, Halldén C, Christensen JJ, Forsgren A, Riesbeck K.

J Bacteriol. 2003 Apr;185(7):2285-95.

49.
50.

Supplemental Content

Loading ...
Support Center